Printed From BioPortfolio.com
[Comment] Extended-release naltrexone: good but not a panacea
20:19 EST 14 Nov 2017 | The Lancet
Unlike other addictions, opioid-use disorder has several highly effective medication treatments available, in particular methadone, buprenorphine, and naltrexone.1–3 Methadone is the least accessible or acceptable of these in many settings, so providers and patients are often faced with a choice between buprenorphine-naloxone (BUP-NX) and extended-release naltrexone injection (XR-NTX).
Original Article: [Comment] Extended-release naltrexone: good but not a panacea
